Medimmune
  • ABOUT MEDIMMUNE
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • OUR CULTURE
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies & Approaches
    • Partnering
  • VENTURES
  • PRESS ROOM
  • CAREERS
  • CONTACT
  • Home >
    • News & Media

News and Media

For press releases:

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Receive E-mail alerts

Subscribe to RSS feeds

December 28, 2006
MedImmune In-Licenses Novel Inflammatory Disease Target
December 20, 2006
MedImmune Licenses Reverse Genetics Technology to CSL for Use in Influenza Vaccine Production
December 19, 2006
MedImmune Strengthens Inflammatory Disease Pipeline Through Collaboration With Biowa
December 18, 2006
MedImmune Completes Sale of CytoGam(R)
December 13, 2006
School-Based Vaccination Study With FluMist(R) Lowers Rates of Flu Among School Community and Families
December 9, 2006
MedImmune's Advancing Cancer Pipeline to Be Highlighted at the American Society of Hematology's Annual Meeting
December 6, 2006
MedImmune Reconfirms 2009 Financial Targets of $2 Billion in Revenues and $2.00 in Earnings Per Diluted Share, Excluding Share-Based Compensation Expense, at 2006 Analyst Day
December 5, 2006
MedImmune Fills Leadership Posts in Two Key Product Development Areas
December 1, 2006
MedImmune's Senior Vice President of Regulatory Affairs Named 'Woman Who Means Business' By Washington Business Journal
November 9, 2006
MedImmune Announces Several Management Promotions
November 9, 2006
MedImmune Files Investigational New Drug Application for Cell Culture-Based Influenza Vaccine
November 8, 2006
MedImmune to Sell CytoGam® to ZLB Behring
November 7, 2006
Infinity and MedImmune Announce Promising Biological Activity of Anti-Hsp90 Compound in Phase I GIST Trial
November 6, 2006
Numax® Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis®
October 26, 2006
MedImmune Reports Financial Results for 2006 Third Quarter and Nine-Month Period
October 13, 2006
Higher Antibody Responses Observed in Young Children Receiving MedImmune's Investigational Intranasal Influenza Vaccine Compared to Injectable Vaccine
October 9, 2006
MedImmune Files Resale Registration Statement for Previously Issued Convertible Senior Notes
September 29, 2006
MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program
September 25, 2006
MedImmune Scientist Honored at Annual Minorities in Research Science Conference
September 13, 2006
MedImmune Breaks Ground on New Biologics Manufacturing Facility in Frederick, Maryland
August 28, 2006
MedImmune and Infinity Pharmaceuticals Announce Cancer Drug Development and Worldwide Commercialization Agreement
August 21, 2006
MedImmune Files Investigational New Drug Application for MT103
August 14, 2006
MedImmune Promotes Ed Mathers to Executive Vice President, Corporate Development and Venture
August 14, 2006
MedImmune Replies to FDA's Complete Response Letter for New Formulation of FluMist®
July 31, 2006
MedImmune Submits Refrigerator-Stable Formulation of FluMist® to FDA for Approval in Younger Children
July 25, 2006
MedImmune Begins Shipping FluMist(R) for 2006-2007 Flu Season
July 20, 2006
MedImmune Reports 2006 Second-Quarter and Six-Month Financial Results
July 18, 2006
MedImmune Receives Complete Response Letter From FDA for New Formulation of FluMist®
July 6, 2006
MedImmune Receives FDA Approval to Use Reverse Genetics Technology for FluMist® Vaccine Production
June 29, 2006
MedImmune Broadens Efforts to Develop Vaccines to Help Prevent RSV and Other Important Pediatric Respiratory Diseases
June 28, 2006
MedImmune Closes Sale of $1.15 Billion Convertible Senior Notes
June 22, 2006
MedImmune Prices $1 Billion Convertible Senior Notes
June 21, 2006
MedImmune to Offer $1 Billion Convertible Senior Notes
June 15, 2006
MedImmune and National Institutes of Health Begin Clinical Testing of a Live, Attenuated Intranasal Vaccine Against an H5N1 Avian Influenza Virus
June 12, 2006
MedImmune Creates New Long-Term Strategic Planning Post
May 25, 2006
MedImmune Authorizes New $500 Million Stock Repurchase Program
May 22, 2006
MedImmune Fills Senior Marketing and Sales Post
May 5, 2006
MedImmune Chairman and Founder Receives Leadership Excellence Award From Robert H. Smith School of Business
May 4, 2006
MedImmune Awarded $170 Million, Five-Year Contract From U.S. Health and Human Services to Develop Cell-Based Influenza Vaccines
May 1, 2006
MedImmune Awards Fellowship Grants in Pediatric Research Totaling $210,000
May 1, 2006
MedImmune and Pediatric Infectious Diseases Society Present 'MedImmune Career Development Award' to Children's Hospital of Philadelphia Pediatrician
May 1, 2006
Phase 3 Study Results of MedImmune's Next-Generation Influenza Vaccine Suggest Better Relative Efficacy Against Matched and Mismatched Strains Compared to the Flu Shot in Young Children
May 1, 2006
MedImmune Presents New Data From Pediatric Studies With FluMist(R) At Pediatric Academic Societies Annual Meeting
April 20, 2006
MedImmune Licenses Elusys Therapeutics' Technology for Use in Developing New Therapies Targeting Infectious Disease
April 20, 2006
MedImmune Reports Financial Results for First Quarter 2006
April 13, 2006
MedImmune Begins Dosing of Lupus Patients in Phase 1 Clinical Trial
April 12, 2006
Lynbrook High School Junior Receives Science Award From MedImmune
April 10, 2006
Additional Preclinical and Clinical Data Indicate Abegrin(TM) May Offer Three-Pronged Approach to Cancer Therapy
April 5, 2006
MedImmune Sponsors AACR Fellowship Grant for Research on Biologics-Based Cancer Therapies
April 3, 2006
MedImmune Adds Substantial Expertise to Commercial Organization With Appointment of Two New Vice Presidents
March 29, 2006
Parkway High School Senior Receives Science Award From MedImmune
March 21, 2006
Montgomery Blair High School Senior Receives Science Award from MedImmune
March 15, 2006
MedImmune Broadens Management Team with Five Additional Leaders in Key Strategic Areas
February 27, 2006
MedImmune Promotes Smullen to Senior Vice President, Sales
February 2, 2006
MedImmune Reports 2005 Financial Results
  • Terms and Conditions
  • |
  • Privacy Policy
  • |
  • Site Map
  • |
  • Contact Us
  • |
  • Glossary
Copyright © 2011 MedImmune, LLC. All rights reserved.